XOMA Royalty (XOMA) News Today $32.70 -0.98 (-2.91%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$32.34 -0.36 (-1.10%) As of 07:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XOMA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Q3 EPS Estimates for XOMA Royalty Lifted by HC WainwrightAugust 26 at 2:11 AM | marketbeat.comHC Wainwright Predicts Stronger Earnings for XOMA RoyaltyAugust 24, 2025 | marketbeat.comAnalysts Set Expectations for XOMA Royalty FY2026 EarningsAugust 24, 2025 | americanbankingnews.comXoma’s Strategic Acquisitions and Innovative Financial Strategies Drive Buy RatingAugust 22, 2025 | tipranks.comMural Oncology and XOMA Royalty Corporation Announce Definitive Agreement for Acquisition of Mural OncologyAugust 20, 2025 | quiverquant.comQMural Oncology to be acquired by XOMA unit for up to $2.24/share in cashAugust 20, 2025 | seekingalpha.comMural Oncology Enters Definitive Agreement for Acquisition by XOMA Royalty Corporation in Cash Deal Valued at Approximately $36.2 MillionAugust 20, 2025 | quiverquant.comQMural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per ShareAugust 20, 2025 | globenewswire.comQ3 EPS Estimates for XOMA Royalty Reduced by Leerink PartnrsAugust 19, 2025 | marketbeat.comLeerink Partnrs Expects Reduced Earnings for XOMA RoyaltyAugust 19, 2025 | americanbankingnews.comLeerink Partnrs Raises Earnings Estimates for XOMA RoyaltyAugust 17, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Rating Increased to Hold at Zacks ResearchAugust 17, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Releases Earnings Results, Beats Estimates By $0.60 EPSAugust 16, 2025 | marketbeat.comXOMA Royalty Corporation Beat Analyst Profit Forecasts, And Analysts Have New EstimatesAugust 16, 2025 | finance.yahoo.comLAVA Therapeutics Announces Acquisition by XOMA CorporationAugust 14, 2025 | tipranks.comXoma Corp. Reports Strong Earnings Growth in 2025August 14, 2025 | msn.comLAVA Therapeutics Enters Agreement to Be Acquired by XOMA Royalty Corporation and Announces Discontinuation of LAVA-1266 DevelopmentAugust 13, 2025 | quiverquant.comQCautious Hold Rating on Xoma Amid Strategic Acquisitions and Uncertain Growth OutlookAugust 13, 2025 | tipranks.comXOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business AchievementsAugust 13, 2025 | globenewswire.comXOMA Royalty Corporation: XOMA Royalty Announces Closing of Tender Offer for Turnstone BiologicsAugust 11, 2025 | finanznachrichten.deXOMA Royalty Announces Closing of Tender Offer for Turnstone BiologicsAugust 11, 2025 | finance.yahoo.comXOMA Royalty (NASDAQ:XOMA) Upgraded to "Buy" at Wall Street ZenAugust 11, 2025 | marketbeat.comInstitutional investors own a significant stake of 43% in XOMA Royalty Corporation (NASDAQ:XOMA)August 10, 2025 | finance.yahoo.comCM Management LLC Grows Stake in XOMA Royalty Corporation (NASDAQ:XOMA)August 7, 2025 | marketbeat.comXOMA Royalty (XOMA) Projected to Post Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comI'm Staying Neutral On XOMA Royalty After The LAVA And HilleVax DealsAugust 6, 2025 | seekingalpha.comHILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVXAugust 5, 2025 | businesswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.August 5, 2025 | prnewswire.comHold Rating on XOMA’s Acquisition of LAVA Therapeutics: Valuation and Risks AssessedAugust 5, 2025 | tipranks.comLAVA Therapeutics stock rises on acquisition deal with XOMA RoyaltyAugust 4, 2025 | investing.comHillevax stock rises after XOMA Royalty announces acquisitionAugust 4, 2025 | investing.comXOMA Royalty Corporation Enters Definitive Share Purchase Agreement to Acquire LAVA Therapeutics N.V.August 4, 2025 | quiverquant.comQHilleVax to be acquired by XOMA RoyaltyAugust 4, 2025 | seekingalpha.comXOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value RightAugust 4, 2025 | globenewswire.comHilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value RightAugust 4, 2025 | globenewswire.comXOMA Royalty (NASDAQ:XOMA) Stock Rating Lowered by Wall Street ZenAugust 3, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?July 26, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Upgraded by Wall Street Zen to "Buy" RatingJuly 26, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Shares Cross Above 200 Day Moving Average - Here's What HappenedJuly 18, 2025 | marketbeat.comESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash TransactionJuly 14, 2025 | prnewswire.comXOMA Royalty (NASDAQ:XOMA) Share Price Crosses Above 200 Day Moving Average - Here's WhyJuly 10, 2025 | marketbeat.comAcuitas Investments LLC Trims Stake in XOMA Royalty Corporation (NASDAQ:XOMA)July 2, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Downgraded by Wall Street Zen to HoldJune 28, 2025 | marketbeat.comXOMA Royalty to Buy Turnstone BiologicsJune 27, 2025 | marketwatch.comTurnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for ...June 27, 2025 | gurufocus.comTurnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for ...June 27, 2025 | gurufocus.comTurnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value RightJune 27, 2025 | globenewswire.comXOMA Royalty (NASDAQ:XOMA) Stock Crosses Above 200 Day Moving Average - Should You Sell?June 24, 2025 | marketbeat.comXOMA Preferred Shares Series A declares $0.539 dividendJune 18, 2025 | seekingalpha.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendJune 18, 2025 | seekingalpha.com Get XOMA Royalty News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XOMA Media Mentions By Week XOMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼0.921.03▲Average Medical News Sentiment XOMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼93▲XOMA Articles Average Week Get the Latest News and Ratings for XOMA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for XOMA Royalty and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies XOMA News Celldex Therapeutics News Novavax News Innoviva News MannKind News Dynavax Technologies News OPKO Health News Geron News Rigel Pharmaceuticals News Zenas BioPharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Royalty Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA Royalty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access